THE Therapeutic Goods
Administration has announced
significant changes to the
regulation of joint implants, with
hip, knee and shoulder implants to
be reclassified as high risk Class III
medical devices.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 02 Jul 12 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 Jul 12
THE Australian Consensus Framework for Ethical Collaboration in the Healthcare Sector was launched in Tokyo last week, with 50 signatories including Pharmacy Guild of Australia, SHPA, ASMI, CMA, CHF, Medicines Australia and NPS Medicinewise.